ArticleInternational journal of molecular sciences2026

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis.

Alessandra Mingione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.